Patients with advanced cancers to take part in promising MUHC clinical trial
Patients with certain advanced cancers could be the first in Canada to test a new therapy at the McGill University Health Centre (MUHC).
The hospital explains that some patients with metastatic pancreatic, lung and breast cancers are being invited to follow in the footsteps of a previous global trial for metastatic prostate cancer, dubbed the LuMIERE clinical trial.
'We are leading the charge in bringing radioligand therapy to Canadian cancer patients,' said Dr. Ramy Saleh, medical director of oncology clinical trials at the Centre for Innovative Medicine (CIM) of the Research Institute at the MUHC. 'This trial is a major milestone that reinforces our role as a national leader in nuclear precision medicine. Our goal is clear: to offer new hope and innovative experimental treatment options to patients who have exhausted conventional therapies.'
The MUHC explains that, unlike chemotherapy, immunotherapy or traditional radiation therapy, radioligand therapy (RTL) utilizes elements called ligands (ions or neutral molecules) and radioisotopes to target and kill cancer cells in the body.
This would be the trial's second phase, following the 'positive results' of phase one, in addition to preclinical studies showing 'significant anti-tumour activity.'
'Radioligand therapy is an exciting new frontier in oncology,' said Saleh. 'Our commitment is to push the boundaries of cancer treatment and bring cutting-edge clinical trials to our patients here in Quebec and in Canada.'
Radioligand therapy involves administering the [177Lu] Lu FAP 2286 drug intravenously to participants of the trial, targeting fibroblast activating proteins (FAPs).
'This therapy is designed to zero in on FAPs, ensuring the radioactive treatment reaches cancer cells while sparing normal tissue,' explains Dr. Farzad Abbaspour, head of the MUHC Nuclear Medicine Division. 'This level of precision could redefine cancer treatment as we know it.'
Participants will first undergo PET scans to confirm the presence of FAPs before being confirmed as part of the trial.
The therapy requires an injection every four weeks for a maximum of four to six injections.
In comparison, immunotherapy treatment typically lasts for at least two years, whereas chemotherapy treatment can be ongoing for a lifetime.
Once the work is done, the radioligands are simply eliminated by the body.
The goal, says Saleh, is to extend patients' lifespans and improve their quality of life.
He adds that there is still no cure for advanced cancers.
People eligible for the trial include those with pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC) and breast cancer.
With files from The Canadian Press.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
2 hours ago
- CBC
Canadian ambassador says there's a 'good path forward' to a trade deal with the U.S.
Social Sharing Canada's ambassador to the United States, Kirsten Hillman said she "firmly" believes that both countries could reach a trade deal within the 30-day deadline discussed at the G7 summit in Alberta last week. "We can't do anything to force the U.S. side to come to a deal, but we do think we have a good path forward if we're able to take it," she said during an interview on Rosemary Barton Live that aired on Sunday. Hillman said it's "too soon to tell" whether all U.S. tariffs imposed on Canada will be removed, and she stopped short of saying whether the federal government is willing to accept the continuation of some tariffs. "These are things that will work themselves out in the next number of weeks," she said. Canada is fighting for "open trade and stability" for Canadian workers and businesses, Hillman said during the interview. WATCH | Canadian ambassador to U.S. discusses ongoing trade talks: Canadian ambassador to U.S. 'firmly' believes in path to trade deal 4 hours ago Duration 9:16 Chief political correspondent Rosemary Barton speaks with Canadian Ambassador to the United States Kirsten Hillman about the ongoing negotiations between Ottawa and Washington. Hillman gets expanded role in Washington Prime Minister Mark Carney appointed Hillman as Canada's chief negotiator with the U.S. amid heightened trade tensions, CBC News has learned. This role comes in addition to her duties as Canada's ambassador to the U.S. Hillman previously worked on the team negotiating the Canada-United States-Mexico Agreement during U.S. President Donald Trump's first term and as Canada's chief negotiator for the Comprehensive and Progressive Agreement for Trans-Pacific Partnership. Her expanded duties now position her in bilateral talks as U.S. Trade Representative Jamieson Greer's counterpart. Trade and defence talks continuing Since Carney and Trump set the 30-day deadline while meeting at the G7 in Kananaskis, Alta., on June 16, Hillman has had three meetings with her U.S. counterparts — one immediately following the leaders' bilateral, the second on the following day with Greer and another on Friday that included Intergovernmental Affairs Minister Dominic LeBlanc, who is also the minister responsible for Canada-U.S. trade. More talks are planned throughout this week. The conversations with the U.S. are focused on different topics, including fentanyl, border security and Arctic defence, although the leaders are focused on tariffs. Hillman said it's still unclear whether defence and trade will be part of one deal coming within the next 30 days. Trump has said "many times" that he likes tariffs, Hillman said. "It's up to Canada to demonstrate we can achieve the same goals with the United States through other means that don't necessarily involve these punishing tariffs, especially on strategic goods." WATCH | PM may raise counter-tariffs on U.S. steel, aluminum if deal delayed: Canada to limit steel imports, may hike U.S. counter-tariffs next month 3 days ago Duration 2:20 Prime Minister Mark Carney has announced limits to foreign steel imports in a bid to prop up Canada's steel industry, which has been hit hard by the U.S. trade war. Canada may hike counter-tariffs on U.S. steel and aluminum if a deal isn't reached by July 21. Steel tariffs still at 50% Just days after Canada and the U.S. set a 30-day deadline, Carney signalled he's willing to go higher with Canada's retaliatory tariffs if no agreement is reached. Canada's counter-tariffs on steel will go up or down, depending on trade progress by July 21, in response to U.S. metal tariffs that are now at 50 per cent. Industry Minister Mélanie Joly told CBC Power & Politics host David Cochrane that Canada is taking "measures like [it's] never done" in the free-trade era to protect the steel and aluminum sectors.
CTV News
3 hours ago
- CTV News
15K Rotarians from 140 countries celebrate community at Calgary convention
Mark Starratt is the co-chair of the host organizing committee of 2025 Rotary International Conventional, which has 15,000 people from 140 different countries attending. Last week, Alberta hosted the G7, which featured global leaders from around the world gathering together in Kananaskis Country to try to solve a few of the world's problems. This week, Calgary is hosting the 2025 Rotary International Convention, which features 15,000 ordinary folks from 140 countries around the world gathering together at BMO Centre in Stampede Park to try to solve a few of the world's problems. "I don't think we have enough time to talk about the variety of things that are being talked about, but it's everything from peace and conflict resolution to polio eradication to literacy, maternal health, and community engagement,' said Mark Starratt, the co-chair of the host organizing committee. 'There's just so many things going on at this convention. It's hard to put a pulse on just one thing." Starratt said there are 13 Rotary Clubs in Calgary and more than 45 in southern Alberta and Saskatchewan, who represent a sliver of the organization's 1.2 million people from 46,000 different clubs. When you put that kind of people to work trying to solve a problem, you can get a lot done, said Rotary International General Secretary and CEO John Hewko. 'Rotary, really, back in 1985, had the the audacity to say we are going to eradicate a disease from the face of the earth,' Hewko said. 'Smallpox have just been eradicated, and we -- to celebrate our 75th anniversary -- said we're going to tackle eradicating polio. John Hewko, Rotary International CEO John Hewko, Rotary International president and CEO (Tyler Barrow, CTV Calgary) 'We were joined by the WHO, UNICEF, CDC, and, more recently, the Gates Foundation and GAVI to create the Global Polio Eradication Initiative. 'We started with 125 countries that had polio back then,' Hewko said. 'We're now down to just two: Afghanistan and Pakistan, where the virus is still circling. So we're on the verge of eradicating polio and leaving a legacy for as long as mankind inhabits the earth.' Hewko said Rotarians around the world have contributed US $2.9 billion to the effort over 40 years, and recently Gates announced he would chip in two dollars for every dollar raised by Rotarians. Not bad for a gathering of not-so-ordinary folks. 'What the polio eradication effort demonstrates is the power of the individual, the power of grassroots organizations to unite together around the cross to drive change and to really make a difference in the world,' Hewko said. Locally, two Calgary Rotary Clubs joined with the Flames Foundation Friday to announce a $3 million donation to build four sports zones in different communities across the city. The convention is believed to be one of the largest Calgary has ever hosted and if there's a problem to be solved in Calgary this week, it might be finding a vacant hotel room or a dinner reservation at a restaurant. All those visitors are expected to book 30,000 hotel room nights and drop around $81 million into the local economy. 'We're delighted to be here in in Calgary,' Hewko said. 'And of course, we're going to be taking advantage of the incredible hospitality of the of the people of Calgary and the City of Calgary.' Rotary International Convention 2025 continues through May 25.
CTV News
3 hours ago
- CTV News
How a Canadian startup is helping kids defy the odds one robotic step at a time
When Marc Robert's son Mitchell was just two years old, doctors delivered a diagnosis no parent is ever prepared for: a rare genetic disorder, epilepsy, and the prognosis that he may never walk. But years later, Mitchell walked nearly a kilometre and a half with his dad at his side, holding back tears. The reason? A pediatric robotic exoskeleton called the Trexo. 'We had one of these devices delivered to him just before COVID closed the world out,' said Robert. 'And I had a background previously in working with guys with acquired brain injuries, so I was able to use my background and then take this tool and start to effect change in him in the way that I was hoping to do.' Trexo Robotics, a Canadian-based company, has created a robotic mobility device specifically engineered for children who can't walk due to conditions like cerebral palsy, muscular dystrophy, or spinal cord injuries. It's designed from the ground up for growing bodies, adapting to their pace and needs. 'The machine itself has motors on the hips and motors on the knees,' explained Robert. 'The way it works is you put a person in there and they move their leg through the range that they're able to do, it measures what they're able to do. Then, through that, we can use the angles that they're able to do and then adjust the motor strengths on the hips and knees to decide how much support it's going to offer.' A Trexo device A Trexo exoskeleton device was photographed on June 22, 2025. (Hannah Schmidt/CTV News) For Robert, and hundreds of families like his, it's been nothing short of transformational. 'It's been a complete game changer for him,' said Robert. 'He's so much stronger and different. He's a different kid than he was five, six years ago. And I know you say that about everybody, but he could barely hold his hand up and now he is a different beast. He can stand up in the shower with me, he can do lots of things because he's strong enough to do it. He's in Grade 5 now. He's probably done 2.7 million steps on the device.' A child uses a Trexo exoskeleton device A child uses a Trexo exoskeleton device in this undated image. Where it all began Trexo's story begins back in 2011 when Manmeet Maggu learned that his nephew, Praneit, was diagnosed with cerebral palsy. Maggu, along with his family, worked tirelessly to find solutions that would allow his nephew to walk. He recruited his friend Rahul Udasi to help him. They both studied robotics at the University of Waterloo and decided on building a robot to help Praneit. That's when the Trexo was born. 'The goal was to build something for him, help him take a few steps, his first few steps,' said Udasi. 'And then after that, it just organically grew. And now we have a lot of families in Canada using the device.' Trexo supports hip and knee movement using motorized joints controlled through a tablet. Over 450 units are now in use across 40 countries in homes and hospitals. In total, Trexo kids have taken more than 125 million steps. 'We take it for granted,' said Udasi. 'We can walk from one place to another. It's not even something we think about. But for a lot of these kids, that's a very difficult problem. It's very rewarding to start helping them move around.' Marc Robert and Mitchell Trexo Marc Robert and his son Mitchell walked side-by-by as Mitchell used a Trexo device on June 22, 2025. (Hannah Schmidt/CTV News) 'It's a game changer' Sara Valenzuela, a mom based in the U.S., first heard about Trexo at a Canadian clinic she brought her son Kenny to. She says she was unsure her son would ever be able to walk. 'My son was born as a micro preemie, born at 25 weeks, one pound ten ounces,' she said. Now, Kenny can stand up and walk around at home and out during excursions. 'Every day we use Trexo,' she said. 'I say it's a game changer for our family, the best equipment that we have. Even with an able-bodied child, just getting to watch a child walk for the first time is a milestone. It's just that moment that you'll always remember. And it's so surreal.' Sara Valenzuela and Kenny Trexo Sara Valenzuela and her son Kenny prepared for an excursion on June 22, 2025. (Hannah Schmidt/CTV News) Next steps Robert and Valenzuela, who now both work directly with Trexo, help families navigate everything from fundraising to insurance paperwork. They know firsthand how intimidating it all can feel. '[The Trexo devices] range between $35,000 and $40,000,' said Robert. 'We did a GoFundMe campaign to be able to offset the cost of it, we also have an arm of our company that helps families do fundraising.' 'We're looking at funding sources through the Ontario government,' said Udasi. 'There's the ADP [Assistive Devices Program]. We're trying to apply to that and see if they can cover the full cost or at least some cost of the device for families." Rahul also said Trexo Robotics won't be slowing down any time soon. 'We're going to make it better, trying to make it work with more types of kids with different conditions.' And kids like Mitchell and Kenny are leading the way — step by step. 'I bawled my eyes the first time I saw him walk with Trexo,' said an emotional Robert. 'I've had the opportunity to put lots of different kids in the machine and watch the parents do exactly what I did and it's probably the most rewarding thing that I've ever got to experience.'
